Cystic Fibrosis

Cystic fibrosis (CF) is an inherited disease affecting approximately 35,000 Americans. Although the condition involves all mucus-producing organs, lung disease accounts for most CF-related illness. Most adult CF patients have lung changes consistent with a diagnosis of bronchiectasis.

In CF airways, metabolic abnormalities result in production of large quantities of abnormally thick, sticky mucus. In early childhood, airways may become inflamed and obstructed with secretions. Retained secretions often contain infection-causing bacteria and tissue-destroying inflammatory by-products.

To minimize the risk for recurrent infection, bacterial colonization and progressive lung disease, lifelong daily airway clearance therapy is a medically necessary standard of care therapy for all CF patients. Significant airway inflammation may be present in infants and young children with CF who have minimal or no evidence of lung disease. The benefits of airway clearance therapy are greatly diminished if treatment is deferred until the development of significant lung disease.

Vest therapy is recognized as a standard of care airway clearance therapy for CF and other lung disorders characterized by impaired mucus clearance. Its status is based upon an abundance of peer-reviewed and other published clinical research – including papers and abstracts presented at major medical conferences – and more than two decades of clinical experience. Airway clearance therapy is recognized as a part of the standard of care for CF and vest therapy has been demonstrated to be a superior form of airway clearance therapy.

Since its introduction in 1988, vest therapy has been associated with markedly improved clinical outcomes including stabilization or improvement in pulmonary function, better general health and extended life expectancy.

Currently, vest therapy ranks as the “first choice” ACT among CF physicians and their patients in the U.S.

  • More than 70% of American CF patients use vest therapy
  • Over 95% of the 115 Cystic Fibrosis Foundation (CFF) – accredited centers prescribe vest therapy for their patients
  • Vest therapy meets all the criteria for airway clearance therapy outlined by the American Association for Respiratory Care (AARC) and the American Physical Therapy Association (APTA)